Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTO

Proteon Therapeutics (PRTO) Stock Price, News & Analysis

Proteon Therapeutics logo

About Proteon Therapeutics Stock (NASDAQ:PRTO)

Key Stats

Today's Range
$3.11
$3.23
50-Day Range
$0.84
$25.13
52-Week Range
$0.22
$3.94
Volume
329,612 shs
Average Volume
1.11 million shs
Market Capitalization
$70.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRTO Stock News Headlines

ProQR Therapeutics price target raised to $4 from $2.50 at Chardan
Protara Therapeutics (TARA) Earnings Dates & Reports
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
ProQR Therapeutics upgraded to Strong Buy from Outperform at Raymond James
ProQR Announces Major Share Offering Agreement
See More Headlines

PRTO Stock Analysis - Frequently Asked Questions

Proteon Therapeutics Inc (NASDAQ:PRTO) posted its quarterly earnings results on Thursday, October, 31st. The biopharmaceutical company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteon Therapeutics investors own include Bristol Myers Squibb (BMY), SCYNEXIS (SCYX), Agile Therapeutics (AGRX), ImmunoGen (IMGN), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
10/31/2019
Today
9/21/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRTO
CIK
1359931
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-118.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.98
Quick Ratio
5.98

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-53.17

Miscellaneous

Outstanding Shares
22,179,000
Free Float
N/A
Market Cap
$70.75 million
Optionable
Not Optionable
Beta
0.60
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PRTO) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners